Actual Medicinal Product (AMP) Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
- Notes
-
Data shows stability for up to 4 weeks.
- Provenance
-
This compatibility recommendation is derived from Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd).
- Generic
- Emtricitabine + Rilpivirine + Tenofovir disoproxil
- Formulation
- Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir disoproxil 245mg tablets
-
Emtricitabine + Rilpivirine + Tenofovir disoproxil
-
Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir disoproxil 245mg tablets
-
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd)
-
-